I’m excited to share a comprehensive look at my professional journey across clinical medicine, translational science, biotechnology leadership, and the evolving landscape of precision and AI-enabled drug development. Over the past two decades, I’ve been fortunate to work with extraordinary teams, lead high-impact programs, and contribute to the growth of organizations committed to improving patient lives. Here is my biography.

Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.